China International Capital Corporation Limited (CICC), established in 1995 as China's first joint venture investment bank, is a prominent provider of financial services. It offers a wide range of services, including investment banking, capital markets, securities sales and trading for both institutions and individuals, fixed income, asset management, private equity, individual wealth management, and research. CICC is also known for its specialized healthcare investment fund, which focuses on buyout opportunities within the healthcare sector. Based in Beijing, CICC continues to play a significant role in the evolving financial landscape of China.
GRIT Biotechnology is a research and development company based in Shanghai, China, focusing on tumor infiltration lymphocytes (TIL) immunotherapy for the treatment of solid tumors. Founded in 2019, the company is dedicated to advancing the field of immunotherapy with the aim of enhancing the effectiveness of tumor treatments. By leveraging innovative approaches in TIL technology, GRIT Biotechnology seeks to provide new therapeutic options for patients battling solid tumors.
ICE Bioscience
Series B in 2023
ICE Bioscience Inc. is a contract research organization based in Beijing, China, specializing in preclinical research solutions for electrophysiology and early drug discovery services. Founded in 2010, the company focuses on the development of ion channel-related pharmaceuticals, particularly targeting the neuronal and cardiovascular systems. ICE Bioscience offers a range of services, including ion channel profiling, cardiac safety panels, brain slice screening, and various molecular biology applications. The company has established proprietary ion channel cell lines for both voltage-gated and ligand-gated channels. Additionally, it maintains a diverse platform for target-based panel screening, supporting drug discovery across multiple therapeutic areas such as immunology, oncology, and CNS diseases. ICE Bioscience is committed to enhancing the drug discovery process through effective communication and flexible collaboration models, aiming to identify and validate drug targets and streamline the progression from compound screening to preclinical candidate selection.
Astronergy
Series C in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
Global Technology
Series C in 2023
Global Technology, headquartered in Shanghai, China, specializes in automotive intelligent driving systems. The company is recognized as a leading supplier in this sector, focusing on advanced electronic active safety products such as Electronic Parking Brakes (EPB), pneumatic and hydraulic Anti-lock Braking Systems (ABS), Electronic Stability Programs (ESP), and Advanced Driver Assistance Systems (ADAS). With a robust emphasis on research and development, Global Technology boasts comprehensive capabilities in vehicle system matching and development. The firm combines design, production, sales, and service functions, supported by a team of senior technical experts in automotive pneumatics, hydraulic brakes, and electronic control. This integration enables the company to provide effective OEM market model matching analysis and forward development capabilities for its clients.
Hydrogen Technology
Venture Round in 2023
Hydrogen Technology focuses on the research and development and industrialization of fuel cell engines. Its main business includes the production and sales of fuel cell engine products and the provision of integrated engineering services for fuel cell vehicles. The company was founded in 2016 and is headquartered in Hangzhou, China.
Vapo Health
Venture Round in 2023
Vapo Health is a medical device company based in Kunshan City, China, focused on developing, manufacturing, and distributing products for respiratory system health. Established in 2015, the company employs advanced nano-scale atomized micro-hole technology to enhance drug delivery and particle efficiency in its offerings. Its product range includes nebulizers, spacers, thermometers, intelligent breathing trainers, and aerosol devices, as well as OEM and ODM services. Vapo Health aims to provide innovative and effective solutions to support respiratory health recovery and improve patient outcomes.
Astronergy
Series B in 2023
Astronergy is a manufacturing firm that specializes in the research, development, and production of solar modules to generate clean energy. Established in 2006, it is recognized as the first large-scale producer of high-efficiency thin film photovoltaic (PV) modules in mainland China. The company is a trusted provider of both monocrystalline and polycrystalline PV modules and focuses on creating high-efficiency crystalline silicon solar cells and modules. These products are designed for various applications, including utility-scale power stations, commercial and industrial PV systems, and residential PV systems. Astronergy aims to deliver high-quality and high-performance photovoltaic solutions to support the global transition to renewable energy.
Beijing Consen Automation
Venture Round in 2022
Beijing Consen Automation specializes in developing automation control systems for the petrochemical industry and railway signal control systems. The company offers comprehensive solutions aimed at enhancing safety and emergency management within the petrochemical sector. Its primary products include safety operation management systems, safety instrumented systems, and various control systems and control valves. Through these offerings, Beijing Consen Automation enables its clients to improve production safety and operational efficiency in their respective industries.
AIForceTech
Series A in 2022
AIForceTech is a company focused on agricultural robotics and smart machinery, based in Beijing's Haidian District since its founding in 2019. The company develops and manufactures a range of electric-powered agricultural products, including unmanned electric tractors and various robotic solutions. Leveraging artificial intelligence and autonomous driving technology, AIForceTech's equipment is designed to operate unmanned around the clock, significantly enhancing agricultural efficiency. The practical application of its products in real-world scenarios has provided the company with valuable operational insights, driving innovation in the agricultural sector.
Safe Medical Evaluation
Series D in 2022
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
ZSHK Laboratories
Series B in 2022
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.
NewBanker
Series C in 2022
NewBanker, through its parent company Beijing Niubitou Science and Technology Consulting, offers a comprehensive suite of services tailored for the wealth management industry. Founded by experienced professionals from prominent Chinese wealth management firms, NewBanker provides essential support that includes information, research, technology, capital, and resources. The company has developed a customer relationship management platform designed specifically for wealth management organizations, featuring a SaaS/PaaS business support system that encompasses various services such as site acquisition, product management, and technical support. Additionally, NewBanker facilitates customer acquisition, strategic research, industry insights, investor education, high-end training, and media promotion, thereby enhancing the operational capabilities of wealth management firms in China.
Sineva
Series C in 2022
Hefei Sineva Intelligent Machine Co., Ltd., established in 2013 and located in Hefei, China, specializes in the research, development, manufacturing, and sales of transfer, test, and service robots. The company operates under the umbrella of Zhejiang Qianjiang Biochemical Co., Ltd. Sineva focuses on providing AI-based machine vision solutions and advanced materials that cater to semiconductor production and drug development. Its business encompasses four main areas: intelligent manufacturing machinery, advanced materials, artificial intelligence, and aircraft. By addressing critical technical gaps in the domestic pan-semiconductor industrial robot sector, Sineva positions itself as a key player in the evolving landscape of intelligent manufacturing.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.
Canhelp Genomics
Series B in 2022
Canhelp Genomics is a prominent healthcare company in China specializing in molecular diagnostics, particularly in oncology. The company aims to enhance patient care by addressing diagnostic uncertainties through reliable and actionable evidence. This approach allows for accurate disease diagnosis and assists physicians in matching patients to personalized treatment options, ultimately improving treatment outcomes in cancer care.
China Resources Vanguard
Funding Round in 2022
China Resources Vanguard, doing business as China Resources Vanguard Shop or Vanguard, operates the supermarket chains of China Resources. It is the third-largest supermarket chain in Hong Kong. As of December 31, 2014, there are 4866 shops operating in Hong Kong and the mainland Chinese provinces/municipalities of Guangdong, Zhejiang, Jiangsu, Shanghai, Tianjin and Beijing. According to market research firm EuroMonitor's estimates in 2012, China Resources Vanguard supermarket market share in Hong Kong is about 7.8%. Wellcome Hong Kong's market share is about 39.8% and PARKnSHOP Hong Kong's market share is about 33.1%. On August 18, 2013, China Resources Enterprise's supermarket chain Vanguard and British supermarket Tesco signed a "memorandum of understanding", intending to set up a joint venture interest group in mainland China, Hong Kong and Macau, operating hypermarkets, supermarkets, convenience stores, liquor stores and cash and carry businesses. China Resources Enterprise took an 80% share and Tesco took a 20% share.
NaaS Technology
Series A in 2022
NaaS Technology is a leading provider of electric vehicle charging services in China, dedicated to enhancing the efficiency of charging facilities and contributing to the country's transition to carbon neutrality. The company offers a comprehensive suite of services to various stakeholders in the electric vehicle sector, including charging pile manufacturers, original equipment manufacturers, delivery fleet companies, and fleet operators. Its solutions encompass online platforms that streamline operations for charging station operators, as well as a range of offline services designed to simplify their daily tasks. Additionally, NaaS Technology provides non-charging services, such as food and beverage options for station operators. With a network of 290,000 linked chargers and an impressive annual charging capacity exceeding 1,200 gigatonnes, NaaS Technology plays a crucial role in supporting structural changes to China’s energy infrastructure.
Tongxin Medical Equipment
Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
DST Car
Series D in 2022
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a company based in Shenzhen, China, specializing in the rental and maintenance of commercial electric vehicles (EVs) for passenger and cargo transportation. Established in 2015, the company focuses on the transportation and logistics sector, providing sustainable energy vehicle rental services tailored for the new energy logistics market. DiShangTie also manufactures electric car charging stations, supporting its commitment to offering green and sustainable vehicle leasing alternatives to major express logistics and urban distribution companies. Through its services, the company aims to facilitate the adoption of environmentally friendly transport solutions in China.
Waytous
Series C in 2022
Waytous is a technology company based in Qingdao, China, specializing in autonomous driving solutions for the mining and construction industries. Founded in November 2014, Waytous develops a cloud-based system that integrates unmanned driving for mining trucks and collaborative operation management for excavators. The company emphasizes the creation of a comprehensive training data and research and development ecosystem to enhance the performance and quality of its intelligent vehicles. Through its innovative technology, Waytous aims to improve operational efficiency and safety in heavy-duty applications.
Value Simplex
Series B in 2021
Value Simplex is a company based in Shanghai, China, specializing in big data and machine learning services tailored for the financial industry. Founded in 2017, it offers a platform that integrates external data with advanced analytical frameworks to enhance investment research. By focusing on the development of intelligent decision-making tools, Value Simplex provides clients with alternative data and knowledge graphs that support accurate projections regarding company performance and product viability. This approach facilitates long-term data accumulation, enabling customers to uncover new insights from time-series data and improve their investment decision-making efficiency.
JYBD
Series B in 2021
JYBD provides a comprehensive service platform for the entire industry chain of the O2O deep integration of the automotive aftermarket. CAB is a comprehensive service platform for the entire industry chain of the O2O deep integration of the automotive aftermarket based on the "industry + internet" model and jointly established by industry channel dealers. Acetin aims to use the Internet to promote the transformation of traditional industries, reduce transaction links, reduce costs, improve industrial efficiency, build a router for the automotive industry, and jointly build a new ecosystem for the automotive aftermarket network. As a platform eco-type Internet enterprise, EPDM has platform service capabilities covering the commercial vehicle + passenger car business group, and On line supply chain + Off line channel operation capabilities, providing service solutions for the entire EPDM industry chain; at the same time as a The service platform for operating 2B & 2C business not only has the ability to integrate offline channels, but also has the full support of many first-class brand supplier groups. Based on the above characteristics, CABNET promotes the Internetization of traditional enterprises, transforms existing businesses with big data, optimizes the supply chain system, reduces costs, improves industrial efficiency, and integrates logistics, capital flow, information flow, business flow, and people flow in a platform-wide industry. The chain is opened, and the scenes of the various after-market transactions in the automotive after-market are presented in a panoramic manner, forming a large ecosystem in which all roles participate together, and eventually becoming an infrastructure platform for the e-commerce transformation of the automotive after-market. Beginning in 2017, the headquarters of EPDM moved to Zhongguancun in Beijing, and the leading companies across the country were formed to form EPDM (Beijing) E-commerce to conduct business nationwide. After years of trial, error correction and accumulation of experience, CABNET has matured its business model. Not only does it have a mature e-commerce system and a well-run model market, it can also have a nationwide offline channel network and a professional operation team. , Has the irreproducible resource advantages of the Chinese tire industry and even the automotive aftermarket. In 2018, the company has successively won tens of millions of CITIC Construction Investment led the Pre-A round, and Manbang Group led the A round of 300 million RMB investment. As of the end of January 2019, it has covered 26 provincial-level administrative regions, 110,000 stores, and 6,200 suppliers. In March, the total monthly platform sales exceeded 500 million yuan, an increase of more than 15% from the previous month, and the annualized transaction volume exceeded 5 billion. yuan. A-People's mission is to "unify the world's stores, so that business is no longer difficult to do"; adhering to the values of customer success and passion; strive to build A-People's Network into an integrated platform for the industry's supply chain, a platform for gathering industry data, and industry standards Output platform. CAB will focus on the automotive aftermarket, unite resources, establish standards, and jointly build a new ecosystem for the automotive aftermarket.
River Security
Series C in 2021
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.
Innoforce Pharmaceuticals
Series A in 2021
Innoforce Pharmaceuticals Co., Ltd is a biopharmaceutical company based in Hangzhou, China, founded in 2018. The company specializes in the development and commercialization of innovative biomedicines, including cell and gene therapies, medicines, and antibodies. Innoforce also operates biologic process development laboratories and offers end-to-end contract development and manufacturing services (CDMO) tailored to support biotech enterprises in their research and development and manufacturing efforts. Through its comprehensive services, Innoforce aids clients in bringing their biopharmaceutical products to market efficiently.
Hua Kong TsingJiao
Series B in 2021
Hua Kong TsingJiao is an IT company established in 2018 and located in Haidian District, Beijing, China. The company specializes in the research, development, and construction of advanced technology centered on modern cryptography and game theory. It has developed a cybersecurity platform that ensures data safety through innovative privacy computing technologies based on multi-party secure computing. This allows multiple non-mutually trusted databases to perform efficient data fusion while maintaining the confidentiality of the data involved. Additionally, its computing platform supports general computing tasks and is compatible with popular libraries like NumPy and PyTorch, thereby simplifying the use of ciphertext calculations for users.
VisionNav Robotics
Series C in 2021
VisionNav Robotics Limited specializes in the design, development, and manufacturing of autonomous industrial vehicles and solutions for intralogistics automation. Founded in 2015 and based in Shenzhen, China, the company utilizes advanced technologies such as artificial intelligence, environmental perception, deep learning, and servo control to create a range of products, including unmanned forklifts and tractors. VisionNav offers a variety of automated vehicles tailored for both indoor and outdoor environments, addressing the needs of sectors such as e-commerce logistics, aviation logistics, and retail. The company has achieved notable advancements in material storage and navigation capabilities, enabling efficient operations in narrow spaces and complex logistics scenarios. With a strong portfolio of projects across over 50 companies in diverse industries, VisionNav Robotics is committed to enhancing global logistics efficiency through innovative driverless solutions.
Orbusneich Medical
Series B in 2021
OrbusNeich Medical is a global medical device manufacturer based in China, specializing in endovascular interventional instruments. Established in 2001, the company has developed a comprehensive range of vascular solutions that are recognized for their industry-leading standards. As of 2023, OrbusNeich's revenue is predominantly generated from its coronary interventional medical devices, including scoring balloons, non-compliant balloons, and stents, which collectively account for 82.7% of total revenue. Geographically, the company derives the largest share of its revenue from Japan (24.7%), followed by Europe, the Middle East, and Africa (23.6%), with the remainder coming from the Asia-Pacific region and the United States. OrbusNeich continues to focus on innovation and quality in its product offerings to improve patient outcomes in vascular interventions.
MediTrust Health
Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.
MicroPort CRM
Series C in 2021
MicroPort CRM is a leading company in Cardiac Rhythm Management, headquartered in Clamart, France. As a subsidiary of MicroPort Scientific Corporation, it specializes in the development, manufacturing, and marketing of advanced medical devices for managing cardiac rhythm disorders and heart failure. The company's product portfolio includes cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems, and ECG diagnostic solutions. With a strong focus on research and development, MicroPort CRM aims to provide innovative treatments for arrhythmias and heart failure, responding to the growing global demand for effective cardiac care solutions driven by an aging population. Manufacturing facilities are located in Clamart, France, Saluggia, Italy, Santo Domingo, Dominican Republic, and Shanghai, China.
CalmCar Vision System
Series C in 2021
CalmCar Vehicle Vision is a Chinese intelligent driving vision system provider. They are specialized in developing intelligent vision system for ADAS, autopilot and autonomous driving with functions of Lane Departure Warning (LDW), Front Collision Warning (FCW), Pedestrian Collision Warning(PCW), Blind Spot Detection (BSD) and Traffic Sign Recognition (TSR).
Leyan Technologies
Series D in 2021
Leyan Technologies is an artificial intelligence company founded in April 2016 and headquartered in Shanghai, China. Specializing in software as a service (SAAS), Leyan develops an AI technology platform that offers digital solutions primarily for the robotics industry. The company's innovations are applied in various sectors, including e-commerce customer service, financial consulting, and medical consultation. By focusing on enhancing human-computer interaction, Leyan Technologies aims to improve customer experiences through intelligent customer service robots and tailored AI applications.
XReal Technology
Series B in 2021
XReal Technology, founded in 2017 and based in Beijing, China, specializes in developing ready-to-wear mixed reality glasses. Their flagship product, Nreal Light, is designed to be lightweight and comfortable, featuring a vivid display and spatial computing algorithms for an immersive user experience. The company's goal is to make mixed reality technology widely accessible and to empower developers to create applications that enhance entertainment, productivity, and other areas. XReal Technology utilizes SLAM-based environment-understanding AI algorithms to provide users with an engaging mixed reality experience.
Ascentawits Pharmaceutical
Series A in 2021
Ascentawits Pharmaceuticals Ltd. is a biotechnology company established in 2014 and located in Shenzhen, China. The company specializes in the development of anti-tumor drugs, focusing on small molecule targeted conjugated therapies. Ascentawits employs innovative drug designs and screening methods that leverage specific tumor micro-environments to create effective treatments for cancer patients. Through its research and development efforts, the firm aims to provide advanced therapeutic options that address the needs of those affected by cancer.
Miaoshou Doctor
Series E in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Dobot
Venture Round in 2021
Dobot is a prominent provider of robotic arm solutions based in China, focusing on making technology accessible and enjoyable. The company specializes in the development of smart desktop robotic arms that enhance manufacturing process efficiency. These robotic arms can be controlled through mobile devices, voice commands, and gestures, offering versatile and responsive solutions tailored for various industries. By integrating full-sensing capabilities, Dobot's products enable users to improve product quality and work efficiency. From its inception with the first desktop robotic arm to the development of STEAM robot kits, Dobot continuously innovates to expand the possibilities of robotic technology.
WeRide
Series B in 2021
WeRide is a leading, commercial-stage global company that develops Level 4 autonomous driving technologies. WeRide aims to develop safe and reliable driverless solutions to make mobility and transportation safer, more affordable and accessible. WeRide is conducting autonomous driving R&D, tests and operations in over 25 cities around the world. As the pioneer leader in autonomous technologies and services, WeRide has stepped up to the commercial stage in operations. WeRide offers an all-rounded product mix of Robotaxi, Robobus, Robovan, Robosweeper and ADAS, providing smart services in online ride-hailing, on-demand transport, urban logistics, sanitation services and acting as a solution provider. Established in 2017, WeRide is headquartered in Guangzhou, China, and has expanded its R&D and operation centers to Beijing, Shanghai, Shenzhen, Zhengzhou, Nanjing, Wuhan, and Anqing, as well as San Francisco in the US. WeRide has formed strategic partnerships with leading global OEMs and Tier 1 supplier including Renault-Nissan-Mitsubishi Alliance, Yutong Group, GAC Group, Bosch, etc.
Core Medical Technology
Series B in 2021
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Singlera Genomics
Series B in 2020
Singlera Genomics Inc. specializes in genetic testing and molecular diagnostic technologies, focusing on non-invasive solutions for cancer screening and diagnosis. The company has developed a methylation detection platform that aids in early tumor detection and cancer prevention. Its offerings include tumor diagnosis, personalized treatment options, non-invasive prenatal diagnosis, and pre-implantation genetic screening, along with customized scientific research services. Founded in 2014 and based in La Jolla, California, Singlera also operates research and development centers in Shanghai, China, and is committed to advancing precision medicine to provide patients with early, accurate, and informative diagnoses.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
SequoiaDB
Series D in 2020
SequoiaDB Corporation is a distributed database company based in Shenzhen, China, established in 2011. It offers a range of products, including SequoiaDB, an enterprise-class distributed relational database designed for online transactions, data centers, and content management applications, as well as SequoiaCM, a solution for managing unstructured data in large and medium-sized enterprises. The company provides services in online transaction processing, content management, and data lake solutions, primarily catering to financial institutions such as banks, insurance firms, and securities companies. SequoiaDB is committed to research and development, aiming to become a global leader in the database industry, and has been recognized in Gartner's reports for its innovative database systems.
LinkDoc
Series D in 2020
LinkDoc Technology Limited, founded in 2014 and headquartered in Beijing, China, specializes in medical data solutions and oncology-focused big data platforms. The company provides structured clinical data to oncology hospitals, aiding them in addressing various scientific and clinical challenges. Additionally, LinkDoc is committed to ensuring patient privacy and data security, adhering to standards set by the US HIPAA Act. The company focuses on delivering continuous care for patients with critical diseases and offers data-driven solutions that support life sciences companies and healthcare professionals in enhancing clinical research and facilitating real-world application of medical advancements.
Thousand Oaks Biopharmaceuticals
Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.
Missfresh
Series E in 2020
Beijing Missfresh E-Commerce Co., Ltd. is an e-commerce platform based in Beijing, China, that specializes in the delivery of fresh grocery products. Founded in November 2014, the company operates a mobile application that allows consumers to conveniently purchase a wide range of items, including fruits, vegetables, dairy products, meat, seafood, beverages, and snacks. Missfresh's services are available in 20 cities across China, providing an integrated online-and-offline shopping experience. The platform emphasizes high-quality fresh food and facilitates quick delivery to customers' doorsteps through its dedicated delivery riders.
Yellow Swan
Series A in 2020
Yellow Swan Edible Fresh Eggs is a domestic enterprise based in Chengdu, Sichuan, China, specializing in the production and retail of bacteria-free eggs. Founded in 2018, the company focuses on providing raw-edible eggs that are free from Salmonella, ensuring higher food safety and quality for consumers. Through its commitment to health standards, Yellow Swan aims to enhance the culinary experience by offering a product that allows for safer consumption of raw eggs.
Jushuitan Network Technology
Series C in 2020
Shanghai Jushuitan Network Technology Co., Ltd. specializes in developing software as a service (SaaS) enterprise resource planning (ERP) solutions. Established in 2014 and headquartered in Shanghai, China, the company offers a range of applications that facilitate order management, warehouse management, supply chain management, and distribution management for e-commerce platforms. In addition to its software solutions, Jushuitan Network Technology is involved in the ownership of intellectual property rights, further enhancing its capabilities in the technology sector.
Mabworks
Series C in 2020
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia.
Suzhou Ribo Life Science
Series C in 2020
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
Abbisko Therapeutics
Series C in 2020
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Lansus Technologies
Series B in 2019
Lansus Technologies Inc. is a fabless semiconductor company based in Shenzhen, China, with a research center in Shanghai. Founded in 2015, the company specializes in developing advanced chip solutions, particularly in radio frequency power amplifiers, switches, and radio-frequency front-end modules. Lansus Technologies provides industrial clients with power amplification solutions utilizing wireless RF devices and systems, catering to sectors such as mobile communications, IoT home furnishings, and industrial electronics. The company focuses on delivering 5G and 4G wireless solutions, promoting technological progress in the radio frequency field while emphasizing sustainable development.
Transwarp
Series D in 2019
Transwarp is a technology company based in Shanghai that specializes in big data software solutions for enterprises. It offers a cloud-based platform that serves as an integrated system for data processing and cloud operations. This platform facilitates the management and analysis of data, allowing businesses to effectively store and govern their data throughout its entire life cycle. Additionally, Transwarp provides services related to data integration, modeling, analysis, mining, and circulation, enabling organizations to harness the full potential of their data infrastructure.
X-Giants
Series A in 2019
X-Giants is a human resources solution provider based in Shanghai, China, founded in 2005. The company specializes in recruitment solutions, offering a range of services that include talent search, recruitment process outsourcing, flexible employment, and personnel outsourcing. In addition to these core services, X-Giants provides consulting and training, as well as salary and benefits management. The company also engages in innovative initiatives, exemplified by its organization of the "blockchain+human resources ecological alliance" launch ceremony, which highlights its commitment to integrating advanced technologies within the HR sector.
JD.com
Series A in 2019
JD.com, Inc., based in Beijing, is a leading e-commerce company in China, operating through its subsidiaries. It offers a wide array of products, from electronics and apparel to food and healthcare items, through its website and mobile apps. JD.com is notable for its extensive logistics network, JD Logistics, which provides efficient and reliable delivery services. The company also operates JD Health, a prominent online healthcare platform offering pharmaceuticals, medical supplies, and online consultations. JD.com's unique selling proposition lies in its self-operated logistics network, ensuring speedy and reliable delivery, and its commitment to providing authentic products. As of 2022, JD.com's gross merchandise volume (GMV) was comparable to Pinduoduo's, but still lower than Alibaba's.
Unisound
Series D in 2019
Beijing Yunzhisheng Information Technology Co., Ltd., also known as Unisound, is a Chinese startup established in June 2012, specializing in intelligent voice and speech processing technologies. The company has developed proprietary speech recognition technologies and utilizes cloud computing to deliver a range of middleware and cloud platforms for speech recognition services. Unisound's offerings cater to both internet enterprises and individual users, providing professional solutions for voice recognition. The core technology team is composed of highly qualified professionals, with over 80% holding doctoral degrees and possessing extensive experience in voice recognition research and development. Additionally, Unisound focuses on Internet of Things (IoT) and artificial intelligence (AI) technologies, enabling efficient communication between users and machines through voice commands, thereby minimizing the need for manual input.
Abbisko Therapeutics
Series B in 2019
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Jusda
Series A in 2019
Jusda International Supply Chain Management Co., Ltd., founded in 2000 and based in Shenzhen, China, specializes in providing comprehensive supply chain management services. The company serves as a platform for freight and logistics solutions, including e-commerce supply chain services on an international scale. As a key service provider for Foxconn Technology Group, Jusda is focused on enhancing the efficiency and professionalism of supply chain management through advanced technology and research and development. Its innovative business model integrates multiple flows—trading, goods, information, capital, technology, and processes—aiming to streamline operations and drive growth within the supply chain sector.
Tenry Pharmaceutical
Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited operates two advanced manufacturing facilities in Shanghai, specializing in the production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company is recognized as a technology-driven enterprise, focusing on the development and commercialization of innovative healthcare solutions. Tenry holds 73 nationally approved drugs and two biological agents, with its primary products aimed at bleeding and wound management. Through its commitment to research and development, along with regulatory compliance, Tenry strives to enhance patient care by providing effective treatment options.
Xingkeduo
Series B in 2018
Xingkeduo is a contemporary hair salon brand based in Beijing, China, that leverages technology to enhance the haircut experience. Established in 2015, the company operates nearly 100 stores and employs over 320 hairdressers. By utilizing Internet tools and big data systems, Xingkeduo standardizes store operations and improves data management, which allows it to offer efficient services to a broad user base. The franchise focuses on providing quick hair styling and cutting services, with an emphasis on 15-minute appointments that can be booked and paid for through WeChat. This approach not only streamlines the customer experience but also aims to improve the livelihoods of the hairdressers involved.
Tuhu
Series E in 2018
Tuhu is a prominent integrated online and offline platform for automotive services in China, catering to car owners' diverse needs through a customer-centric model. The company offers same-day or next-day delivery and installation of automobile after-sales products in over 260 cities across mainland China. Tuhu's services are accessible via its website, mobile app, call center, and third-party e-commerce platforms. By streamlining its supply chain and providing a digitalized, on-demand service experience, Tuhu effectively connects car owners, suppliers, and automotive service stores. Its platform accommodates a wide range of passenger vehicle models and fulfills various automotive service demands, including tire and chassis parts replacement, maintenance, repair, and detailing.
Makeblock
Series C in 2018
Makeblock is a company founded in 2013 and headquartered in Shenzhen, China, that offers a do-it-yourself (DIY) robotics construction and programming learning platform. This platform provides mechanical components, various electronic modules, and graphical programming software, allowing STEM and STEAM learners, educators, and hobbyists to design and build modular, programmable robots. Users can create diverse robotic applications, including hovercrafts and cars, fostering hands-on learning and creativity in robotics and programming.
Shanghai Henlius Biotech
Venture Round in 2018
Shanghai Henlius Biotech, Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the research, development, production, and commercialization of biologics, particularly monoclonal antibody (mAb) biosimilars and novel therapies. Founded in 2010, the company focuses on oncology and autoimmune diseases, offering products such as HLX01, a biosimilar for treating non-Hodgkin lymphoma. Henlius is actively advancing its pipeline, with multiple products under review for regulatory approval, alongside conducting numerous clinical studies for various therapies. The company collaborates with partners, including agreements to develop treatments for COVID-19 and eye diseases. Shanghai Henlius Biotech is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, established in 2009, and operates out of the Shanghai Caohejing High-Technology Park.
Xpeng Motors
Series B in 2018
Xpeng Motors is a Chinese electric vehicle and technology company that specializes in the design and manufacture of smart cars. The company emphasizes local market needs and prioritizes consumer experience, integrating advanced autonomous driving features and internet-connected technologies into its vehicles. This approach aims to enhance the overall functionality and appeal of their cars, making them more than just traditional vehicles. Additionally, Xpeng Motors has a subsidiary, Xpeng Robotics, which focuses on developing smart robots as part of its broader mobility ecosystem.
Zing Home
Corporate Round in 2017
Zing Home is a Shenzhen-based household products and furniture retail brand. It currently operates in 46 cities across China with over 160 offline stores.
Gaosi Education Group
Series C in 2017
Gaosi Education Group is a Chinese educational institution specializing in extracurricular tutoring for middle and primary school students. Founded in December 2009, it is headquartered in Beijing's Haidian District. The group focuses on gifted education, offering tailored courses for students from primary through junior high school. It features personalized one-on-one teaching centers and emphasizes mathematics competitions as a key component of its curriculum. With nearly 10,000 students enrolled, Gaosi Education Group employs around 100 full-time teachers and staff dedicated to teaching and research.
United Imaging Healthcare
Series A in 2017
United Imaging Healthcare develops and manufactures medical equipment and solutions. Its solutions cover areas of diagnostics, radiotherapy, and healthcare information technology solutions. United Imaging Healthcare offers medical imaging products such as computed tomography, molecular imaging, magnetic resonance, and X-ray radiography products, radiotherapy equipment, and uCloud UIH Intelligent Medical Cloud, a medical cloud platform for medical resource sharing and mass diagnostic data mining. It also provides customer, technical support, dispatching, and training services. United Imaging Healthcare began operation in 2011, with its headquarters in Shanghai in China. It has locations in Concord, Cleveland, Houston, Wuhan, and Shenzhen.
Distinct HealthCare
Series C in 2017
Distinct Healthcare operates a network of private healthcare clinics across six cities in China, including Shenzhen, Hong Kong, Guangzhou, and Beijing. Founded in 2012, the company provides a range of medical services, including pediatrics, internal medicine, gynecology, and family medicine. Their offerings cover common health issues such as colds, headaches, diabetes, and chronic kidney disease, as well as emergency support and referrals to specialists. Distinct Healthcare also conducts various examinations and laboratory tests, including imaging and blood tests, in collaboration with affiliated hospitals. The company emphasizes patient-oriented care and strives to minimize unnecessary antibiotic prescriptions and excessive examinations, ensuring quality medical services through experienced medical professionals. Additionally, Distinct Healthcare offers nursing services and well baby plans, enhancing comprehensive healthcare for families. The company has established a strategic partnership with Tencent Holdings Limited to further enhance its services.
SenseTime
Series B in 2017
SenseTime Group Limited is an artificial intelligence company specializing in computer vision and deep learning technologies. Founded in 2014 and headquartered in Beijing, China, the company develops a wide range of AI solutions, including face and body analysis, image and video recognition, autonomous driving technologies, and medical image analysis. SenseTime's proprietary AI infrastructure, SenseCore, supports scalable and efficient AI software platforms tailored for various applications across sectors such as smart cities, intelligent transportation, healthcare, and finance. The company is also active in advancing industry standards related to data security and ethical AI practices, having contributed to numerous national and international guidelines. With a presence in multiple countries, including Japan, Singapore, and several locations in China, SenseTime aims to drive innovation and foster sustainable productivity through its AI technologies.
QingCloud
Series D in 2017
QingCloud is a cloud computing platform based in China that specializes in Infrastructure as a Service (IaaS). The company offers a range of flexible cloud services, including support for private networks, hourly billing, open APIs, comprehensive monitoring, and multiple real-time data security policies. Founded by former professionals from Tencent, Baidu, and IBM, QingCloud aims to create a highly optimized IaaS platform inspired by the model of major industry players. Richard, the company's CEO, has emphasized QingCloud's ambition to evolve into a globally recognized cloud platform. The company plans to initiate expansion efforts in the Asia Pacific region, aiming to broaden its international presence and enhance its service offerings to meet the demands of the digital landscape.
NetEase Cloud Music
Series A in 2017
NetEase Cloud Music, established in 2013 and based in Hangzhou, China, specializes in online music streaming services through its mobile application. The platform enables users to access a wide variety of music and offers additional features, such as music discovery and social networking capabilities. As a subsidiary of NetEase, Inc., NetEase Cloud Music has grown to become a significant player in the Chinese music streaming market, catering to the evolving preferences of its audience while developing applications for smartphones to enhance user experience.
UCloud Information Technology
Series D in 2017
UCloud Information Technology provides IaaS (base cloud computing), independent research and development, computational resource, storage resource, network resource, and other basic IT infrastructure services. It offers UCloud Physical Host that provides physical servers, UCloud Host, a UCloud-based mature cloud computing technology, UCloud Load Balancer, a load balancing service that offers automatic allocation of application data among multiple cloud hosts, UCloud Network, a UCloud network service that manages network resources, and UCloud Extended Hybrid Cloud that offers a hybrid deployment service of cloud platforms and server hosting. UCloud Information Technology also provides UCloud Disk that provides permanent hard disk storage space for cloud hosting, UCloud DataBase, a data base service based on mature cloud computing technology, UCloud Memory Storage, a key-value memory database, UCloud Content Delivery Network services, Object Storage that provides unstructured file storage services for Internet applications, UCloud Distributed Data Processing solutions, Cloud Security that provides testing services, and scheduling interface solutions for cloud computing resources. It serves video, O2O and E-Commerce, Internet finance, PaaS/SaaS, game, mobile SNS, online education, and digital marketing sectors. Ji Xinhua, Hua Kun, and Mo Xianfeng founded UCloud Information Technology in 2011. Its headquarters is in Shanghai in China.
Lachesis
Series A in 2017
Lachesis is a high-tech company based in Shenzhen, China, specializing in clinical applications that integrate information and communications technology with internet technology. The company develops intelligent products and services aimed at enhancing the efficiency of healthcare delivery for doctors, nurses, patients, and hospitals. Its offerings include a bedside nursing solution, an interactive smart ward solution, and an IoT platform, all designed to improve management efficiency and accuracy in medical assessments. By providing mobile medical intelligent hardware and application software, Lachesis aims to advance mobile nursing and intelligent medical practices within healthcare institutions.
Chunyu Yisheng
Series D in 2016
Chunyu Yisheng is a mobile application that enables physicians and their patients to communicate with each other. The application provides physicians with access to their patients’ medical records. Furthermore, it enables the patients to communicate and schedule appointments with the doctors. In addition, it offers reservation line treatment services to its users. Chunyu Yisheng was launched in 2011 by Rui Zhang and is based in Beijing.
UCAR Technology
Series C in 2016
UCAR Technology, established in 2015 and headquartered in Tianjin, China, is a prominent provider of chauffeured car services. The company operates an on-demand car-hailing platform that connects customers with local licensed drivers through their smartphones. UCAR combines mobile internet technology, big data, and a fleet of quality rental vehicles to ensure safe and standardized transportation. The company's services include both chauffeured car options and vehicle rentals, with a focus on driver qualifications and vehicle conditions. UCAR employs advanced technologies to monitor driver behavior, ensuring privacy protection and efficient response to accidents, thereby enhancing the overall customer experience.
Bairong
Series B in 2016
Bairong is an independent technology platform based in China that specializes in providing financial information services to large companies. Utilizing artificial intelligence, cloud computing, and blockchain technology, Bairong aims to innovate and digitally transform the financial services industry. The company focuses on exploring various scenarios and applications of these advanced technologies, enabling financial institutions to enhance their operations and promote financial inclusion. Through its AI-powered solutions, Bairong supports financial institutions in navigating the complexities of the modern financial landscape.
Tellyes Scientific
Post in 2015
Tellyes Scientific Inc. specializes in the manufacture and marketing of healthcare equipment aimed at the medical education and training sectors. Founded in 2001 and headquartered in Tianjin, China, the company offers a diverse range of products, including patient simulators, surgical simulators, ultrasound and imaging simulators, task trainers, and dental simulators. Tellyes Scientific also provides solutions for planning and managing training centers and engages in tele-simulation. The company's innovative approach encompasses research and development in various fields, including training software and traditional Chinese medicine training systems. With a portfolio of over a thousand types of medical virtual teaching products, Tellyes Scientific serves a global market through a network of distributors across Asia, Africa, the Middle East, Europe, North America, and Latin America.
Daoyoudao
Post in 2015
Daoyoudao is a technology company based in Beijing, China, specializing in digital marketing services. It focuses on user growth for clients across various sectors, including internet, education, and automotive industries. Daoyoudao acquires new users through digital effect marketing strategies such as information flow advertising and short video advertising. Additionally, the company activates existing users by employing programmatic content awakening techniques to enhance customer engagement.
Wacai.com
Series B in 2015
Wacai is a Chinese mobile app developer specializing in personal finance management through its widely-used mobile application. Since its launch in 2009, the app has provided users with bookkeeping services and expanded its functionality to include mutual fund trading in 2013. In 2014, Wacai introduced a credit card manager feature, which has become increasingly popular among users in China. The app aims to help individuals manage their finances effectively by offering tools for personal bookkeeping, credit management, and an online community for financial assistance. With a user base exceeding 40 million, Wacai continues to enhance its platform to meet the evolving needs of its clientele.
Zhong An
Series A in 2015
ZhongAn Online P & C Insurance Co., Ltd. is an insuretech company based in Shanghai, China, founded in 2013 by prominent enterprises including Ant Financial, Tencent, and Ping An Insurance. As the first internet-based insurance provider in China, ZhongAn exclusively offers its products and services online, eliminating the need for physical branches. The company specializes in property and casualty insurance, providing coverage for accidents, health, liability, cargo, household property, and motor-related incidents. In addition to insurance, ZhongAn also delivers a range of technology services, including IT consulting, asset management, and telemedicine solutions. The company's technological capabilities extend to developing digital operating systems and industry models, which are offered to financial institutions both domestically and internationally. With a focus on e-commerce and mobile payment solutions, ZhongAn supports internet businesses and individual users through financing guarantees and innovative online services.
Lufax
Series A in 2015
Lufax is a technology-driven personal financial services platform based in China and affiliated with Ping An Insurance. The company specializes in various financial services, including wealth management and retail credit facilitation. Lufax offers a range of services related to financial asset transactions, including investment services for institutions and individual investors, as well as transaction financing consulting. Its comprehensive platform supports financial asset allocation and transaction organization, enabling clients to manage their financial needs effectively. Through its innovative approach, Lufax aims to enhance financial accessibility and efficiency for its users.
Chunyu Yisheng
Series C in 2014
Chunyu Yisheng is a mobile application that enables physicians and their patients to communicate with each other. The application provides physicians with access to their patients’ medical records. Furthermore, it enables the patients to communicate and schedule appointments with the doctors. In addition, it offers reservation line treatment services to its users. Chunyu Yisheng was launched in 2011 by Rui Zhang and is based in Beijing.
New China Life Insurance
Venture Round in 2011
New China Life Insurance Company Ltd., founded in 1996 and headquartered in Beijing, is a prominent life insurance provider in the People's Republic of China. The company offers a diverse range of life insurance products catering to individual and institutional clients, with a focus on areas such as accidental injury, medical treatment, endowment, children's education, and family finance. It operates through three primary segments: Individual Insurance Business, Group Insurance Business, and Other Business. New China Life is recognized for its extensive distribution network, covering all provinces and regions in China, and utilizes various sales channels to reach customers. In addition to insurance products, the company engages in asset management, training, electronic commerce, medical services, and real estate investment activities. It emphasizes risk control as a vital aspect of its operations, supported by a comprehensive risk management system developed with the assistance of global consulting firms. New China Life ranks among the largest life insurers in China, reflecting its significant market presence and commitment to protecting the interests of its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.